Category | Overall (N=676) | Ever on biologics | ||
No (n=611) | Yes (n=56) | P value | ||
Age at survey (years), mean±SD | 48.4±13.6 | 48.5±13.5 | 46.9±14.3 | 0.39 |
Age at diagnosis (years), mean±SD | 32.5±12.1 | 32.5±12.1 | 32.7±12.2 | 0.9 |
Disease duration (years), mean±SD | 15.9±9.8 | 16.1±9.9 | 14.2±8.4 | 0.17 |
Gender (female), n (%) | 630 (93.2) | 568 (93.0) | 53 (94.6) | 0.63 |
Race (black), n (%) | 545 (80.6) | 495 (81.0) | 41 (73.2) | 0.16 |
Education (years), mean±SD | 14.5±3.1 | 14.5±3.1 | 15.2±3.0 | 0.1 |
Currently employed, n (%) | 241 (35.7) | 220 (36.0) | 20 (35.7) | 0.97 |
Married or with a partner, n (%) | 219 (32.4) | 200 (32.7) | 19 (33.9) | 0.8 |
Below 100% poverty level, n (%) | 244 (36.1) | 228 (37.3) | 13 (23.2) | 0.030 |
Insurance type, n (%) | ||||
No insurance | 66 (9.8) | 64 (10.5) | 1 (1.8) | 0.036 |
Private | 231 (34.2) | 211 (34.5) | 19 (33.9) | |
Medicare | 181 (26.8) | 156 (25.5) | 22 (39.3) | |
Medicaid | 186 (27.5) | 171 (28.0) | 12 (21.4) | |
Disease activity (SLAQ), mean±SD | 16.0±9.3 | 16.0±9.3 | 16.4±9.3 | 0.77 |
Organ damage (BILD), n (%) | ||||
No damage | 81 (12.0) | 75 (12.3) | 5 (8.9) | 0.76 |
Mild damage | 237 (35.1) | 213 (34.9) | 20 (35.7) | |
Severe damage | 358 (53.0) | 323 (52.9) | 31 (55.4) | |
Poor/fair health status, n (%) | 340 (50.3) | 310 (50.7) | 27 (48.2) | 0.66 |
Organ damage, n (%) | ||||
Eye damage | 232 (34.3) | 209 (34.2) | 19 (33.9) | 0.97 |
Neurological damage | 100 (14.8) | 90 (14.7) | 9 (16.1) | 0.79 |
Renal damage | 57 (8.4) | 53 (8.7) | 4 (7.1) | 0.69 |
Pulmonary damage | 98 (14.5) | 91 (14.9) | 7 (12.5) | 0.63 |
Heart damage | 172 (25.4) | 154 (25.2) | 18 (32.1) | 0.26 |
Vascular damage | 131 (19.4) | 114 (18.7) | 16 (28.6) | 0.073 |
Gastrointestinal damage | 159 (23.5) | 139 (22.7) | 18 (32.1) | 0.11 |
Muscle/bone damage | 147 (21.7) | 135 (22.1) | 12 (21.4) | 0.91 |
Skin damage | 58 (8.6) | 54 (8.8) | 4 (7.1) | 0.67 |
Early menopause | 70 (15.9) | 62 (15.5) | 7 (20.0) | 0.49 |
Diabetes | 74 (10.9) | 62 (10.1) | 11 (19.6) | 0.029 |
Cancer | 60 (8.9) | 55 (9.0) | 4 (7.1) | 0.64 |
Early menopause responses were from women only.
BILD: no damage (score=0), mild damage (score=1–2), severe damage (score ≥3).
9 participants did not provide biologic information.
BILD, Brief Index of Lupus Damage; GOAL, Georgians Organized Against Lupus; SLAQ, Systemic Lupus Activity Questionnaire.